Eyeworld

SEP 2021

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/1400530

Contents of this Issue

Navigation

Page 98 of 106

Using Photrexa ® Viscous (riboflavin 5'-phosphate in 20% dextran ophthalmic solution), Photrexa ® (riboflavin 5'-phosphate ophthalmic solution), and the KXL ® system, the iLink ™ corneal cross-linking procedure from Glaukos is the only FDA-approved therapeutic treatment for patients with progressive keratoconus and corneal ectasia following refractive surgery.* 1 NOW FROM GLAUKOS GET THERE IN TIME iLink ™ is the only FDA-approved cross-linking procedure that slows or halts progressive keratoconus to help you preserve vision. INDICATIONS Photrexa ® Viscous (riboflavin 5'-phosphate in 20% dextran ophthalmic solution) and Photrexa ® (riboflavin 5'-phosphate ophthalmic solution) are indicated for use with the KXL System in corneal collagen cross-linking for the treatment of progressive keratoconus and corneal ectasia following refractive surgery. Corneal collagen cross-linking should not be performed on pregnant women. IMPORTANT SAFETY INFORMATION Ulcerative keratitis can occur. Patients should be monitored for resolution of epithelial defects. The most common ocular adverse reaction was corneal opacity (haze). Other ocular side effects include punctate keratitis, corneal striae, dry eye, corneal epithelium defect, eye pain, light sensitivity, reduced visual acuity, and blurred vision. These are not all of the side effects of the corneal collagen cross-linking treatment. For more information, go to www.livingwithkeratoconus.com to obtain the FDA-approved product labeling. You are encouraged to report all side effects to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. * Photrexa ® Viscous and Photrexa ® are manufactured for Avedro. The KXL System is manufactured by Avedro. Avedro is a wholly owned subsidiary of Glaukos Corporation. REFERENCE: 1. Photrexa [package insert] Waltham, MA: Glaukos, Inc. 2016. MA-01953A Glaukos® is a registered trademark of Glaukos Corporation. iLink™ is a trademark of Glaukos Corporation. Photrexa®, Photrexa® Viscous, and the KXL® system are registered trademarks of Avedro, a Glaukos company. All rights reserved. © 2021 Now from GLAUKOS LEARN MORE AT GLAUKOS.COM

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld - SEP 2021